In The News
CIDRZ Receives Grant from the Bill & Melinda Gates Foundation to Identify Ways to Retain HIV-Infected Persons in Care
WASHINGTON, DC, August 28, 2014 - Accordia Global Health Foundation congratulates the Centre for Infectious Disease Research in Zambia (CIDRZ) and CIDRZ CEO, Dr. Charles Holmes, Deputy CEO, Dr. Izukanji Sikazwe, and Dr Elvin Geng of the University of California San Francisco (UCSF) on the receipt of a $4.76 million award from the Bill & Melinda Gates Foundation to support the Better Information for Health in Zambia study.
WASHINGTON DC, August 19, 2014 - In a new paper, published today, Professor Marcia Weaver and colleagues report an overview of the findings from the Integrated Infectious Disease Capacity-Building Evaluation (IDCAP).
Accordia Global Health Foundation, with funding from the Bill & Melinda Gates Foundation, launched IDCAP to better equip mid-level practitioners to manage infectious diseases and to advance the global health community’s understanding of the cost-effectiveness of innovative training approaches. IDCAP created a state-of-the-art package of training interventions that incorporated three key elements: 1) a focus on mid-level practitioners, 2) integration across infectious diseases, and 3) on-site support.
For Immediate Release
WASHINGTON, DC, May 8, 2014 – Ambassador Eric Goosby, former U.S. Global AIDS Coordinator and current Professor of clinical medicine at the University of California, San Francisco (UCSF), has been elected to the Accordia Global Health Foundation Board of Directors.
“I am delighted to welcome Ambassador Goosby to our board of directors,” said Hank McKinnell, Chair of the Board of Directors for Accordia Global Health Foundation. “He brings a valuable perspective having spearheaded a global effort to manage the scaling up of sustainable HIV/AIDS treatment capacity which has impacted millions. Our board is looking forward to benefitting from Ambassador Goosby’s vast experience particularly his successful efforts building public private partnership opportunities as we move forward to expand our network of centers of excellence in Africa.”
On Monday, April 21, 2014, Warner C. Greene, MD, PhD, Executive Chair of Accordia Global Health Foundation and Founding Director of the Gladstone Institute of Virology and Immunology was elected to the celebrated American Academy of Arts and Sciences. Founded, in 1780, the Academy’s purpose is "to cultivate every art and science which may tend to advance the interest, honor, dignity, and happiness of a free, independent, and virtuous people."
2013 Summit on Child Wellness Report
Accordia Global Health Foundation is pleased to name Dr. Faith Osier as the 2014 recipient of the prestigious Merle A. Sande Health Leadership Award. An external selection committee convened by Accordia chose Dr. Osier to receive the award, from a large pool of highly qualified applicants hailing from 8 African countries.
Faith Osier, MD, PhD, is a pediatrician whose work focuses on the development of effective malaria vaccines, through the identification of targets and mechanisms underlying naturally acquired immunity. She is currently a Clinical Research Fellow and Group Leader at the Kenya Medical Research Institute (KEMRI)– Centre for Geographic Medicine Research.
Watch the PBS News Special Search for a Cure
WASHINGTON, DC—January 10, 2014—Accordia Global Health Foundation joins many in the global health community in congratulating Dr. Deborah Brix on her nomination to be the new Ambassador at Large and Coordinator of United States Government Activities to Combat HIV/AIDS Globally. The nomination was announced on Jan. 9 for Dr. Brix to succeed Ambassador Eric Goosby, who left the position to return to clinical research and practice.
Accordia has had a long-standing relationship with PEPFAR, working to combat HIV/AIDS in Africa. Please visit the “what we do” section of Accordia’s website to learn more about our work.
Additional information about the nomination is available in a press release from the White House.
Ten Years of Advancing Excellence in African Healthcare
Gladstone Institutes to launch Phase 2 trial with existing anti-inflammatory
For more information or media inquiries please contact Alissa Oram (Phone: 202-534-1200, Email: firstname.lastname@example.org).